Stromal target-CAR-iNKT

N/A

Report date: 2025/01/26 17:16:55

Base Information

Drug NameStromal target-CAR-iNKT
Drug Alias Nameanti-stromal CAR iNKT-cell therapy(MiNK Therapeutics Inc)allogeneic iNKT cell-based immunotherapy (MiNK Therapeutics Inc)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunostimulantsNatural killer T-lymphocyte stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMiNK Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMiNK Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A